Conversely, MYD88 L625P gain-of-function mutation, found in the vast majority of LPL, was identified only in 73% of DLBCL transformed from LPL in a recent study [29,38,41]. This evidence concerns the gene MYD88 and diffuse large B-cell lymphoma.